Literature DB >> 3112011

The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period.

A C Vu, H M Foy, F D Cartwright, G E Kenny.   

Abstract

To determine whether antigenic variation in protein antigens of Mycoplasma pneumoniae occurred over time, 12 isolates obtained from pneumonia patients over a 10-year period (1964 to 1974) were compared by immunoblotting (Western blotting) against acute and convalescent human serum samples obtained from the same patients. The strains selected were isolated from patients who had low anti-lipid complement-fixing antibody titers in their acute-phase serum samples and high titers in their convalescent-phase serum samples. The polypeptide composition of the strains was closely similar by protein staining even when compared with prototype FH-Liu. On immunoblotting, all strains showed five bands (170, 130, 90, 45, and 35 kilodaltons [kDa]) which were stained more intensely by convalescent-phase than by acute-phase specimens. A sixth band (62 kDa) was detected by the conjugate alone. In FH-Liu, one band (110 kDa) was prominently stained by convalescent-phase specimens; this band was much less apparent in all of the clinical isolates. Two isolates possessed an additional band (92 kDa) which was stained more prominently by some but not all convalescent-phase specimens. Because of its known antigenic relationships and culture similarities, Mycoplasma genitalium was used for comparison. More polypeptides of M. genitalium than of M. pneumoniae were recognized by acute-phase serum samples, and 4 of 12 convalescent-phase serum samples showed increases in antibodies to certain M. genitalium polypeptides. However, these reactive polypeptides did not correspond in molecular mass to polypeptides recognized in M. pneumoniae; thus the signature profile of human convalescent-phase specimens with M. pneumoniae was distinct. These five polypeptides, individually or in combination, are especially promising for use in detection of human serum antibodies by enzyme-linked immunosorbent assay because they were found in all M. pneumoniae isolates tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112011      PMCID: PMC260609          DOI: 10.1128/iai.55.8.1830-1836.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS.

Authors:  G E ENNY; J T GRAYSTON
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

2.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

3.  Demonstration of multiple antigenic determinants on Mycoplasma pneumoniae attachment protein by monoclonal antibodies.

Authors:  P C Hu; C H Huang; Y S Huang; A M Collier; W A Clyde
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.

Authors:  E Jacobs; A Bennewitz; W Bredt
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

5.  Heat-lability and organic solvent-solubility of mycoplasma antigens.

Authors:  G E Kenny
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

6.  Antimetabolic antibodies to Mycoplasma pneumoniae measured by tetrazolium reduction inhibition.

Authors:  L B Senterfit; K E Jensen
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

7.  A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production.

Authors:  D Taylor-Robinson; R H Purcell; D C Wong; R M Chanock
Journal:  J Hyg (Lond)       Date:  1966-03

8.  Detection of the major adhesin P1 in triton shells of virulent Mycoplasma pneumoniae.

Authors:  I Kahane; S Tucker; D K Leith; J Morrison-Plummer; J B Baseman
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group.

Authors:  E R Alexander; H M Foy; G E Kenny; R A Kronmal; R McMahan; E R Clarke; W A MacColl; J T Grayston
Journal:  N Engl J Med       Date:  1966-07-21       Impact factor: 91.245

10.  Antigenic determinants of the attachment protein of Mycoplasma pneumoniae shared by other pathogenic Mycoplasma species.

Authors:  W A Clyde; P C Hu
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

View more
  21 in total

1.  Indirect enzyme-linked immunosorbent assay for detection of immunoglobulin G reactive with a recombinant protein expressed from the gene encoding the 116-kilodalton protein of Mycoplasma pneumoniae.

Authors:  M F Duffy; K G Whithear; A H Noormohammadi; P F Markham; M Catton; J Leydon; G F Browning
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence.

Authors:  L Papazisi; S Frasca; M Gladd; X Liao; D Yogev; S J Geary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Identification of a mycoplasmal protein which binds immunoglobulins nonimmunologically.

Authors:  A G Alexander; H R Lowes; G E Kenny
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome.

Authors:  K Ruland; R Wenzel; R Herrmann
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

5.  Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

6.  Sequence divergency of the cytadhesin gene of Mycoplasma pneumoniae.

Authors:  C J Su; A Chavoya; S F Dallo; J B Baseman
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Restriction fragment length polymorphism in the cytadhesin P1 gene of human clinical isolates of Mycoplasma pneumoniae.

Authors:  S F Dallo; J R Horton; C J Su; J B Baseman
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  Molecular distinctions among clinical isolates of Mycoplasma pneumoniae.

Authors:  C J Su; S F Dallo; J B Baseman
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

9.  Rapid immunoblot method for diagnosis of acute Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Thomas; P J Middleton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

10.  Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark. A 30 years survey.

Authors:  K Lind; M W Bentzon
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.